Skip header and navigation

Narrow By

56 records – page 3 of 3.

Syndrome de sevrage néonatal

https://libcat.nshealth.ca/en/permalink/chpams37507
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2203
Available Online
View Pamphlet
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison. ; This pamphlet is a French translation of the English pa…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
Neonatal abstinence syndrome
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison.
This pamphlet is a French translation of the English pamphlet 2144, "Neonatal abstinence syndrome". Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2203
Less detail

Taking care of your lung health

https://libcat.nshealth.ca/en/permalink/chpams38248
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4058
Available Online
View Pamphlet
Lung cancer is 1 of the 4 most common cancers in Nova Scotia. This pamphlet explains what you can do to take care of your lung health and lists possible signs and symptoms of lung cancer.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - prevention & control
Lung Neoplasms
Subjects (LCSH)
Lungs--Cancer--Prevention
Abstract
Lung cancer is 1 of the 4 most common cancers in Nova Scotia. This pamphlet explains what you can do to take care of your lung health and lists possible signs and symptoms of lung cancer.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4058
Less detail

Taking part in a clinical trial

https://libcat.nshealth.ca/en/permalink/chpams35766
Nova Scotia Health Authority. NSHA Research & Innovation. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1723
Available Online
View Pamphlet
This pamphlet describes what is involved in taking part in a clinical trial. It explains what clinical trials are, why they are important and the benefits of taking part. If you are considering taking part in a clinical trial, a list of questions you may want to ask is also included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. NSHA Research & Innovation
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6 p.]) : digital, PDF file
Subjects (MeSH)
Clinical Trials as Topic
Subjects (LCSH)
Clinical trials
Specialty
Hospitals
Abstract
This pamphlet describes what is involved in taking part in a clinical trial. It explains what clinical trials are, why they are important and the benefits of taking part. If you are considering taking part in a clinical trial, a list of questions you may want to ask is also included.
Responsibility
Prepared by: NSHA Research & Innovation
Pamphlet Number
1723
Less detail

Taking your medication

https://libcat.nshealth.ca/en/permalink/chpams34640
Nova Scotia Health Authority. Mental Health and Addictions Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0758
Available Online
View Pamphlet
Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed. The French version of this pamphlet 1916, "Prendre vos médicaments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Psychiatry
Medication
Subjects (LCSH)
Drugs
Mental Health
Specialty
Medications
Abstract
Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed. The French version of this pamphlet 1916, "Prendre vos médicaments", is also available.
Responsibility
Prepared by: Mental Health and Addictions Program
Pamphlet Number
0758
Less detail

Taking your medications when you are sick after a kidney transplant

https://libcat.nshealth.ca/en/permalink/chpams35858
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1805
Available Online
View Pamphlet
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Medications
Subjects (LCSH)
Kidneys--Transplantation
Drugs
Specialty
Nephrology
Medications
Abstract
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot keep fluids down without vomiting is included.
Notes
Previous title: Taking your medications when you are ill after a kidney transplant : a guide for patients with a kidney transplant
Responsibility
Prepared by: Kidney Transplant Clinic, QEII
Pamphlet Number
1805
Less detail

Taking your medicines when you are sick: a guide for patients with chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams36519
Nova Scotia Health Authority. NSHA Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1340
Available Online
View Pamphlet
This pamphlet lists medications to avoid when you are sick while managing chronic kidney disease. The pamphlet includes instructions for what to do if you are throwing up or have diarrhea, what to do if you are diabetic, as well as what to do if you are unsure whether to take a certain medication. It also gives a page for writing a sick day plan.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. NSHA Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases
Abstract
This pamphlet lists medications to avoid when you are sick while managing chronic kidney disease. The pamphlet includes instructions for what to do if you are throwing up or have diarrhea, what to do if you are diabetic, as well as what to do if you are unsure whether to take a certain medication. It also gives a page for writing a sick day plan.
Notes
Previous title: Taking your Medicines when you are Ill - A Guide for Patients with Chronic Kidney Disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1340
Less detail

Transjugular liver biopsy : Valley Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams36466
Nova Scotia Health Authority. Interventional Radiology Provincial Committee. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1923
Available Online
View Pamphlet
A transjugular liver biopsy is done to remove a small piece of tissue from your liver using a thin needle. The tissue will be sent to the lab, where it will be looked at under a microscope. Who will do the biopsy, possible complications, and how long you can expect to be at the hospital is listed. How to get ready, and what happens during and after the biopsy is covered. Follow-up care, and symptoms requiring a visit to your doctor are outlined. A list of medications and how long to stop taking…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Interventional Radiology Provincial Committee
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Liver Diseases - diagnosis
Biopsy, Needle
Subjects (LCSH)
Liver--Diseases--Diagnosis
Liver--Biopsy
Abstract
A transjugular liver biopsy is done to remove a small piece of tissue from your liver using a thin needle. The tissue will be sent to the lab, where it will be looked at under a microscope. Who will do the biopsy, possible complications, and how long you can expect to be at the hospital is listed. How to get ready, and what happens during and after the biopsy is covered. Follow-up care, and symptoms requiring a visit to your doctor are outlined. A list of medications and how long to stop taking them both before and after the biopsy is provided for you to look at with your doctor.
Responsibility
Prepared by: Interventional Radiology Provincial Committee
Pamphlet Number
1923
Less detail

Ultrasound guided percutaneous kidney biopsy : Valley Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams36467
Nova Scotia Health Authority. Interventional Radiology Provincial Committee. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1924
Available Online
View Pamphlet
An ultrasound guided percutaneous kidney biopsy is done to remove at least 3 tiny pieces of tissue from your kidney using a thin needle. The tissue will be sent to the lab, where it will be looked at under a microscope. Who will do the biopsy, possible complications, and how long you can expect to be at the hospital is listed. How to get ready, and what happens during and after the biopsy is covered. Follow-up care, and symptoms requiring a visit to your doctor are outlined. A list of medicatio…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Interventional Radiology Provincial Committee
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diagnosis
Biopsy, Needle
Subjects (LCSH)
Kidney--Diseases--Diagnosis
Kidney--Biopsy
Abstract
An ultrasound guided percutaneous kidney biopsy is done to remove at least 3 tiny pieces of tissue from your kidney using a thin needle. The tissue will be sent to the lab, where it will be looked at under a microscope. Who will do the biopsy, possible complications, and how long you can expect to be at the hospital is listed. How to get ready, and what happens during and after the biopsy is covered. Follow-up care, and symptoms requiring a visit to your doctor are outlined. A list of medications and how long to stop taking them both before and after the biopsy is provided for you to look at with your doctor.
Responsibility
Prepared by: Interventional Radiology Provincial Committee
Pamphlet Number
1924
Less detail

Ultrasound guided percutaneous liver biopsy : Valley Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams36465
Nova Scotia Health Authority. Interventional Radiology Provincial Committee. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1922
Available Online
View Pamphlet
An ultrasound guided percutaneous liver biopsy is done to remove at least 3 tiny pieces of tissue from your kidney using a thin needle. The tissue will be sent to the lab, where it will be looked at under a microscope. Who will do the biopsy, possible complications, and how long you will be at the hospital are covered. How to get ready for a liver biopsy, and what happens during and after the biopsy is listed. Follow-up care, and symptoms requiring a visit to your doctor are outlined. A list of…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Interventional Radiology Provincial Committee
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Liver Diseases - diagnosis
Biopsy, Needle
Subjects (LCSH)
Liver--Diseases--Diagnosis
Liver--Biopsy
Abstract
An ultrasound guided percutaneous liver biopsy is done to remove at least 3 tiny pieces of tissue from your kidney using a thin needle. The tissue will be sent to the lab, where it will be looked at under a microscope. Who will do the biopsy, possible complications, and how long you will be at the hospital are covered. How to get ready for a liver biopsy, and what happens during and after the biopsy is listed. Follow-up care, and symptoms requiring a visit to your doctor are outlined. A list of medications and how long to stop taking them both before and after the biopsy is provided for you to look at with your doctor.
Responsibility
Prepared by: Interventional Radiology Provincial Committee
Pamphlet Number
1922
Less detail

Using TENS for pain

https://libcat.nshealth.ca/en/permalink/chpams35692
Nova Scotia Health Authority. Physiotherapy Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0727
Available Online
View Pamphlet
This pamphlet will help you learn how to use a TENS (transcutaneous electric nerve stimulation) unit at home. It explains pain, how a TENS unit works and how to use it, taking care of your skin, taking care of the unit, and safety guidelines.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Physiotherapy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Transcutaneous Electric Nerve Stimulation
Subjects (LCSH)
Transcutaneous electric nerve stimulation
Abstract
This pamphlet will help you learn how to use a TENS (transcutaneous electric nerve stimulation) unit at home. It explains pain, how a TENS unit works and how to use it, taking care of your skin, taking care of the unit, and safety guidelines.
Responsibility
Prepared by: Physiotherapy Services
Pamphlet Number
0727
Less detail

Ustekinumab (Stelara) therapy

https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1695
Available Online
View Pamphlet
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ustekinumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Ulcerative colitis
Specialty
Medications
Abstract
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taking ustekinumab and while you are taking it are listed. Possible side effects, information about pregnancy and breast/chest feeding, and other important things to know are included.
Notes
Previous title: Ustekinumab (Stelara) therapy for Crohn's disease
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1695
Less detail

Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2307
Available Online
View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Subjects (LCSH)
Kidneys--Diseases--Treatment
Specialty
Nephrology
Medications
Abstract
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2307
Less detail

Welcome to the Maternal/Child Unit : Aberdeen Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams35941
Nova Scotia Health Authority. Aberdeen Regional Hospital. Maternal/Child Unit. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1884
Available Online
View Pamphlet
This pamphlet explains what you will need to know when coming to the Maternal/Child Unit (MCU) at Aberdeen Regional Hospital. There are lists of what you should bring for yourself, the baby, and your support person. Information provided about the MCU includes phone service, snacks, visitors, and smoking. Details about the day of delivery, taking care of mom and baby, keeping baby safe, discharge, and paperwork are also included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Regional Hospital. Maternal/Child Unit
Alternate Title
Welcome to the Maternal Child Unit (MCU) : Aberdeen Regional Hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Maternal Health
Nursing units
Subjects (LCSH)
Maternal health services
Hospital wards
Abstract
This pamphlet explains what you will need to know when coming to the Maternal/Child Unit (MCU) at Aberdeen Regional Hospital. There are lists of what you should bring for yourself, the baby, and your support person. Information provided about the MCU includes phone service, snacks, visitors, and smoking. Details about the day of delivery, taking care of mom and baby, keeping baby safe, discharge, and paperwork are also included.
Responsibility
Prepared by: MCU, Aberdeen Regional Hospital
Pamphlet Number
1884
Less detail

What you need to know about taking antioxidants during your radiation therapy

https://libcat.nshealth.ca/en/permalink/chpams37528
Nova Scotia Health Authority. Cancer Care Program, Nova Scotia Health Authority. Cancer Care Program Education Team. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4015
Available Online
View Pamphlet
Antioxidants are nutrients found in some foods and also in supplements such as pills. Antioxidants help your body protect and repair your cells from damage to keep them working normally. The goal of radiation therapy is to damage your cancer cells. Taking antioxidants may prevent your radiation treatment from working as well as it should because it may prevent some of the damage we are trying to cause to your cancer cells. This pamphlet explains whether you should take antioxidants during radia…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Nova Scotia Health Authority. Cancer Care Program Education Team
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neoplasms
Radiation
Subjects (LCSH)
Cancer
Radiation
Specialty
Cancer Care
Abstract
Antioxidants are nutrients found in some foods and also in supplements such as pills. Antioxidants help your body protect and repair your cells from damage to keep them working normally. The goal of radiation therapy is to damage your cancer cells. Taking antioxidants may prevent your radiation treatment from working as well as it should because it may prevent some of the damage we are trying to cause to your cancer cells. This pamphlet explains whether you should take antioxidants during radiation therapy, what vitamins and supplements you can take, and whether you can eat foods with antioxidants in them. Where to get more information is also included.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Health Cancer Care Program Education Team
Pamphlet Number
4015
Less detail

Women and Children's Health Unit : Yarmouth Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams35893
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1838
Available Online
View Pamphlet
This pamphlet explains what you will need to know when coming to the Women and Children's Health Unit (WCHU) at Yarmouth Regional Hospital. There are lists of what you should bring for yourself and the baby, as well as what your support person should bring. Information provided about the Unit includes phone and television service, visitors, and smoking. Details about the day of delivery, taking care of yourself and baby, keeping baby safe, discharge, and paperwork are also included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Maternal Health
Nursing units
Subjects (LCSH)
Maternal health services
Hospital wards
Abstract
This pamphlet explains what you will need to know when coming to the Women and Children's Health Unit (WCHU) at Yarmouth Regional Hospital. There are lists of what you should bring for yourself and the baby, as well as what your support person should bring. Information provided about the Unit includes phone and television service, visitors, and smoking. Details about the day of delivery, taking care of yourself and baby, keeping baby safe, discharge, and paperwork are also included.
Notes
Previous title: Welcome to the Maternal/Child Unit : Yarmouth Regional Hospital
Responsibility
Prepared by: Women and Children's Health Unit, Yarmouth Regional Hospital
Pamphlet Number
1838
Less detail

Women and Children's Unit : Cumberland Regional Health Care Centre

https://libcat.nshealth.ca/en/permalink/chpams38144
Nova Scotia Health Authority. Cumberland Regional Health Care Centre. Women and Children's Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2314
Available Online
View Pamphlet
This pamphlet explains what you will need to know when coming to the Women and Children's Unit at Cumberland Regional Health Care Centre. There are lists of what you should bring for yourself and the baby, as well as what your support person should bring. Information is provided about the unit, visitors, and smoking. Details about the day of delivery, taking care of yourself and baby, keeping baby safe, discharge, and paperwork are also included. A list of resources is also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cumberland Regional Health Care Centre. Women and Children's Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Maternal Health
Nursing units
Subjects (LCSH)
Maternal health services
Hospital wards
Abstract
This pamphlet explains what you will need to know when coming to the Women and Children's Unit at Cumberland Regional Health Care Centre. There are lists of what you should bring for yourself and the baby, as well as what your support person should bring. Information is provided about the unit, visitors, and smoking. Details about the day of delivery, taking care of yourself and baby, keeping baby safe, discharge, and paperwork are also included. A list of resources is also provided.
Responsibility
Prepared by: Women and Children's Unit, Cumberland Regional Health Care Centre
Pamphlet Number
2314
Less detail

56 records – page 3 of 3.